AVTX filings
Corporate insider profile
Mitchell Chan Filing Activity
Latest reported as Director of Avalo Therapeutics, Inc. (AVTX).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$72,460.96
- Latest transaction
- May 6, 2026
Affiliated corporations
Reported company relationships
Transaction history
